Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application;Endophthalmitisrate mit und Ohne Topische Postoperative Antibiotikagabe nach Intravitrealer Avastin-Injektion

Ophthalmologe

Volumn 104, Issue 11, 2007, Pages 952-957

  Meyer, C H ^a,b,c   Mennel, S ^b,c   Eter, N ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Für Die Avastin Datenbank   (Germany)

Author keywords

Antibiotics; Endophthalmitis; Intraocular inflammation; Intravitreal injection; Vascular endothelial growth factor inhibitors

Indexed keywords

EID: 36549057141     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-007-1634-6     Document Type: Article

References (24)

1. Aggio FB, Farah ME, Melo GB de et al. (2007) Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection. Eye 21: 408-409
2. Aiello LP, Brucker AJ, Chang S et al. (2004) Evolving guidelines for intravitreous injections. Retina 24: S3-19
3. Apt L, Isenberg SJ (1994) Infectious endophthalmitis after cataract surgery. Br J Ophthalmol 78: 948-949
4. Barkana Y, Almer Z, Segal O et al. (2005) Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting. Acta Ophthalmol Scand 83: 360-363
5. Binder CA, Mino de Kaspar H, Klauss V et al. (1999) Preoperative infection prophylaxis with 1% polyvidon-iodine solution based on the example of conjunctival staphylococci. Ophthalmologe 96: 663-667
6. Brown DM, Kaiser PK, Michels M et al. (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 1432-1444
7. Dwinger MC, Pieper-Bodeewes I, Eter N et al. (2005) Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection. Klin Monatsbl Augenheilkd 222: 638-642
8. Ferguson AW, Scott JA, McGavigan J et al. (2003) Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol 87: 163-167
9. Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90: 1344-1349
10. Jaissle GB, Szurman P, Bartz-Schmidt KU, German Retina Society; German Society of Ophthalmology, German Professional Association of Ophthalmologists (2005) Recommendation for the implementation of intravitreal injections - statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monatsbl Augenheilkd 222: 390-395
11. Johnson MW, Doft BH, Kelsey SF et al. (1997) The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology 104: 261-272
12. Jonas JB, Spandau UH, Rensch F et al. (2007) Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. Ocul Pharmacol Ther 23: 240-242
13. Kiss C, Michels S, Prager F et al. (2006) Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab. Retina 26: 877-281
14. Kreissig I, Degenring RF, Jonas JB (2006) Intravitreal triamcinolone acetonide Complication of infectious and sterile endophthalmitis. Ophthalmologe 103: 30-34
15. Ladewig MS, Ziemssen F, Jaissle G et al. (2006) Intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmologe 103: 463-470
16. Lalitha P, Rajagopalan J, Prakash K et al. (2006) Postcataract endophthalmitis in South India incidence and outcome. Ophthalmology 112: 1884-1889
17. Maeck CR, Eckardt C, Holler C (1990) Preoperative disinfection of the conjunctiva with PVP-iodine. Fortschr Ophthalmol 87: 320-323
18. Meyer CH, Callizo J, Mennel S et al. (2007) Perioperative management of anticoagulated patients undergoing repeated intravitreal injections. Arch Ophthalmol 125: 994
19. Pieramici DJ, Avery RL, Castellarin AA et al. (2006) Case of anterior uveitis after intravitreal injection of bevacizumab. Retina 26: 841-842
20. Rodrigues EB, Meyer CH, Grumann A et al. (2007) Tunneled scleral incision for intravitreal injections. Am J Ophthalmol 143: 1035-1037
21. Rosenfeld PJ, Brown DM, Heier JS et al. (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431
22. Simon A, Fleischhack G, Wiszniewsky G et al. (2006) Influence of prolonged use of intravenous administration sets in paediatric cancer patients on CVAD-related bloodstream infection rates and hospital resources. Infection 34: 258-263
23. Westfall AC, Osborn A, Kuhl D et al. (2005) Acute endophthalmitis incidence: intravitreal triamcinolone. Arch Ophthalmol 123: 1075-1077
24. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group; D'Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET, Guyer DR, Katz B (2006) Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113: 992-1001